MORRISVILLE, N.C.--(BUSINESS WIRE)--Trimeris, Inc. (NASDAQ: TRMS) today announced financial results for the three months ended December 31, 2006, reporting total revenues of $12.5 million, an increase of 57 percent, compared to the same period last year. This increase was primarily influenced by strong global sales of FUZEON which reached $73.3 million, a growth of 16 percent over the same period last year. All sales of FUZEON are recorded by F. Hoffmann-La Roche Ltd (“Roche”), Trimeris’ collaborative partner.
